GRIFOLS ITALIA S.P.A.
ItalyAll drugs from this manufacturer
-
It is used to replenish and maintain circulating blood volume in patients who have lost blood or body fluids and for whom the use of a plasma substitute (colloid) is indicated.
Dosage form: solution for infusion
Active substance Dosage human albumin - ATC: B05AA01
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (factor VIII deficiency) and for the treatment of acquired deficiency of this factor. It is also indicated for hemophilia A patients who have developed antibodies against factor VIII and for the prophylaxis or treatment of bleeding in von Willebrand disease, when treatment with desmopressin is ineffective or contraindicated.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage von willebrand factor - human coagulation factor viii - ATC: B02BD06
-
It is used to treat and prevent bleeding in people with Hemophilia B (congenital factor IX deficiency) or in subjects with an acquired factor IX deficiency.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human coagulation factor ix - ATC: B02BD04
-
It is used to prevent an increased risk of blood clot formation (deep vein thrombosis or thromboembolism) in people with antithrombin deficiency, whether congenital or acquired, during surgical procedures or around the time of childbirth.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human antithrombin iii - ATC: B01AB02
-
It is used for chronic therapy in individuals with a hereditary alpha-1 antitrypsin deficiency. It serves to restore balance in the lungs and to prevent the worsening of pulmonary emphysema.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human alpha1-proteinase inhibitor - ATC: B02AB02
-
It is used for the treatment and prevention of bleeding episodes in people with hemophilia A (factor VIII deficiency), for the treatment of acquired factor VIII deficiency, and for patients with antibodies against factor VIII. It is also indicated for the treatment of von Willebrand disease and to prevent bleeding related to surgical procedures in patients where desmopressin is ineffective or contraindicated.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage factor viii - von willebrand factor - ATC: B02BD06
-
It is used to replenish and maintain blood volume in patients who have lost blood or body fluids and for whom the use of a colloid is indicated.
Dosage form: solution for infusion
Active substance Dosage human albumin - ATC: B05AA01